SCHEMBL4351946

SCHEMBL4351946

O=C(Nc1ccc(Cl)cc1)N(S)c1cc(Cl)ccc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX1 P51575 4/20 0.53
TSHR P16473 1/20 0.50
ERCC1 P07992 1/20 0.46
ERCC4 Q92889 1/20 0.46
RAB9A P51151 2/20 0.45
PKM P14618 1/20 0.45
TMPRSS4 Q9NRS4 4/20 0.43
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
NPC1 O15118 3/20 0.42
ALOX15 P16050 2/20 0.42
P2RX4 Q99571 2/20 0.42
P2RX7 Q99572 2/20 0.42
KCNMA1 Q12791 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CA12 O43570 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4342062 0.91 TMPRSS4 (0.55) P2RX1TSHRRAB9ATMPRSS4NPC1
SCHEMBL4341696 0.90 P2RX1 (0.54) P2RX1TSHRRAB9ATMPRSS4P2RX4
SCHEMBL4353933 0.88 TMPRSS4 (0.60) P2RX1TMPRSS4P2RX4P2RX7MEN1
SCHEMBL4353445 0.82 TSHR (0.47) P2RX1TSHRRAB9APKMNPC1
SCHEMBL4345618 0.79 TSHR (0.47) P2RX1TSHRERCC1ERCC4RAB9A
SCHEMBL4358489 0.78 SMN1; SMN2 (0.42) RAB9APKMNPC1ALOX15ALDH1A1
SCHEMBL4341747 0.77 TSHR (0.45) P2RX1TSHRRAB9APKMNPC1
SCHEMBL4348078 0.77 TSHR (0.45) P2RX1TSHRERCC1ERCC4RAB9A
SCHEMBL4343809 0.77 TSHR (0.47) TSHRRAB9APKMNPC1ALOX15
SCHEMBL4345461 0.76 TSHR (0.44) P2RX1TSHRRAB9APKMNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 P2RX1 2577/4885TSHR 1112/4885ERCC1 4459/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 P2RX1 2600/4885TSHR 1455/4885ERCC1 4521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.